LCM
ACET icon

Laurion Capital Management’s Adicet Bio ACET Stock Holding History

Laurion Capital Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,970
Closed -$282K – 432
2022
Q4 		$282K Sell
1,970
-3,708
-65% -$925K ﹤0.01% 376
2022
Q3 		$1.29M Sell
5,678
-21,917
-79% -$5.56M 0.01% 358
2022
Q2 		$6.45M Hold
27,595
– – 0.1% 139
2022
Q1 		$8.82M Sell
27,595
-4,593
-14% -$1.06M 0.11% 126
2021
Q4 		$9.01M Buy
32,188
+15,000
+87% +$2.57M 0.09% 144
2021
Q3 		$2.16M Hold
17,188
– – 0.01% 430
2021
Q2 		$2.83M Sell
17,188
-4,141
-19% -$843K 0.02% 337
2021
Q1 		$4.46M Buy
+21,329
New +$4.9M 0.02% 342

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Laurion Capital Management's ACET Position: Q1 2023 in Review

Laurion Capital Management sold out of Adicet Bio (ACET) in Q1 2023, closing a stake of 1,970 shares — an estimated $282K sold.

Laurion Capital Management first reported a position in ACET in Q1 2021 and held it in 8 quarters. The position peaked at $9.01M in Q4 2021. 107 funds tracked by Wall St. Rank hold ACET as of Q1 2023.

  • Laurion Capital Management reported no remaining Adicet Bio position as of Q1 2023 after selling out during the quarter.
  • Laurion Capital Management sold 1,970 Adicet Bio shares in Q1 2023, an estimated $282K.
  • Laurion Capital Management first reported a position in Adicet Bio in Q1 2021 and held it in 8 quarters.
  • Laurion Capital Management's Adicet Bio position peaked at $9.01M in Q4 2021.
  • 107 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2023.

Based on Laurion Capital Management's 13F filing for Q1 2023, filed 15 May 2023.